As of 2025-12-20, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (13.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.24 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -359.8%.
The range of the Relative Valuation is (9.77) - (18.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.5x | 9.9x |
| Forward P/E multiples | 7.7x - 15.3x | 11.5x |
| Fair Price | (9.77) - (18.49) | (13.61) |
| Upside | -286.4% - -452.9% | -359.8% |
| Date | P/E |
| 2025-12-19 | -4.11 |
| 2025-12-18 | -3.92 |
| 2025-12-17 | -3.64 |
| 2025-12-16 | -3.51 |
| 2025-12-15 | -3.43 |
| 2025-12-12 | -3.48 |
| 2025-12-11 | -3.51 |
| 2025-12-10 | -3.49 |
| 2025-12-09 | -3.43 |
| 2025-12-08 | -3.49 |
| 2025-12-05 | -3.42 |
| 2025-12-04 | -3.59 |
| 2025-12-03 | -3.48 |
| 2025-12-02 | -3.36 |
| 2025-12-01 | -3.45 |
| 2025-11-28 | -3.72 |
| 2025-11-26 | -3.77 |
| 2025-11-25 | -3.70 |
| 2025-11-24 | -3.58 |
| 2025-11-21 | -3.62 |
| 2025-11-20 | -3.60 |
| 2025-11-19 | -3.81 |
| 2025-11-18 | -3.94 |
| 2025-11-17 | -3.77 |
| 2025-11-14 | -3.68 |
| 2025-11-13 | -3.42 |
| 2025-11-12 | -3.55 |
| 2025-11-11 | -3.48 |
| 2025-11-10 | -3.47 |
| 2025-11-07 | -3.42 |
| 2025-11-06 | -3.14 |
| 2025-11-05 | -3.14 |
| 2025-11-04 | -2.77 |
| 2025-11-03 | -3.30 |
| 2025-10-31 | -3.46 |
| 2025-10-30 | -3.38 |
| 2025-10-29 | -3.32 |
| 2025-10-28 | -3.49 |
| 2025-10-27 | -3.23 |
| 2025-10-24 | -3.19 |
| 2025-10-23 | -3.06 |
| 2025-10-22 | -3.14 |
| 2025-10-21 | -3.19 |
| 2025-10-20 | -3.17 |
| 2025-10-17 | -3.13 |
| 2025-10-16 | -3.38 |
| 2025-10-15 | -3.47 |
| 2025-10-14 | -3.41 |
| 2025-10-13 | -3.36 |
| 2025-10-10 | -3.18 |